Managing Pain in Geriatric and Pediatric Populations
T-DXd Rechallenge After Grade 1 ILD Appears Safe, Study Finds
Trastuzumab Rezetecan Yields High Intracranial Remission Rates in HER2-Positive BC With Brain Metastases
OptiTROP-Breast05: Sacituzumab Tirumotecan Shows 71% ORR in Advanced TNBC